ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer

Breast Cancer trials near Budapest, Budapest, HUN:

Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer (POLAR)

-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this study, anti-h...

Enrolling
Breast Cancer Recurrent
Drug: Standard endocrine therapy
Drug: Palbociclib 125mg

Phase 3

ETOP IBCSG Partners Foundation

Budapest, Hungary and 52 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

Phase 3

Pfizer
Pfizer

Budapest, Hungary and 324 other locations

To compare and evaluate the efficacy and safety of Liporaxel® solution (oral paclitaxel) and Taxol® (IV paclitaxel) on recurrent or metastatic breast...

Active, not recruiting
Recurrent or Metastatic Breast Cancer
Drug: Oral paclitaxel
Drug: Paclitaxel injection

Phase 2, Phase 3

Daehwa Pharmaceutical

Tatabánya, Hungary and 50 other locations

with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...

Active, not recruiting
Breast Cancer
Drug: Vinorelbine
Drug: Eribulin

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 166 other locations

mg in postmenopausal women with oestrogen receptor positive advanced breast cancer who have failed on a previous endocrine treatmen...

Active, not recruiting
Breast Cancer
Drug: Fulvestrant

Phase 3

AstraZeneca
AstraZeneca

Székesfehérvár, Hungary and 102 other locations

PREcoopERA is a randomized (2:2:1), multicenter, open-label, three-arm (A, B, C), Window-of-Opportunity (WOO) trial to evaluate the activity and safe...

Enrolling
Breast Cancer
Drug: Anastrozole
Drug: Giredestrant

Phase 2

ETOP IBCSG Partners Foundation

Budapest, Hungary and 43 other locations

growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Nab-Paclitaxel
Drug: Trastuzumab deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 293 other locations

adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer with intermediate-high or high risk for disease recurren...

Enrolling
Breast Cancer, Early Breast Cancer
Drug: Letrozole
Drug: Exemestane

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 464 other locations

Locations recently updated

to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with intermediate or high risk for disease recurrence...

Enrolling
Breast Cancer, Early Breast Cancer
Drug: Anastrozole
Drug: Exemestane

Phase 3

AstraZeneca
AstraZeneca

Budapest, Hungary and 692 other locations

with hormone receptor-positive (HR-positive), HER2-negative advanced breast cancer (aBC) who have not received prior therapy for ad...

Active, not recruiting
Breast Cancer
Drug: Goserelin
Drug: Ribociclib

Phase 2

Novartis
Novartis

Budapest, Hungary and 89 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems